Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Akebia Therapeutics Inc. (AKBA)

4.27   0.06 (1.43%) 07-15 16:00
Open: 4.24 Pre. Close: 4.21
High: 4.29 Low: 4.14
Volume: 455,422 Market Cap: 503M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.292 - 4.318 4.318 - 4.343
Low: 4.08 - 4.11 4.11 - 4.138
Close: 4.223 - 4.268 4.268 - 4.311

Technical analysis

as of: 2019-07-15 4:40:09 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 5.43     One year: 5.84
Support: Support1: 4.08    Support2: 3.39
Resistance: Resistance1: 4.65    Resistance2: 5.00
Pivot: 4.40
Moving Average: MA(5): 4.25     MA(20): 4.42
MA(100): 6.13     MA(250): 7.11
MACD: MACD(12,26): -0.16     Signal(9): -0.18
Stochastic oscillator: %K(14,3): 16.67     %D(3): 17.75
RSI: RSI(14): 42.10
52-week: High: 10.73  Low: 4.08  Change(%): -57.5
Average Vol(K): 3-Month: 113984  10-Days: 80727

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AKBA has closed above bottom band by 33.4%. Bollinger Bands are 47.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to AKBA's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 09 May 2019 19:58:00 Z
Akebia Therapeutics, Inc. (AKBA) Q1 2019 Earnings Call Transcript

Thu, 09 May 2019 15:03:08 Z
Akebia Therapeutics (AKBA) Reports Q1 Loss, Lags Revenue Estimates

Thu, 02 May 2019 17:19:12 Z
Will Akebia Therapeutics (AKBA) Report Negative Earnings Next Week? What You Should Know

Wed, 10 Apr 2019 16:12:30 Z
Akebia Expands Vadadustat Licensing Deal With Vifor Pharma

Tue, 19 Mar 2019 07:06:40 Z
Akebia Therapeutics (AKBA) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 117.86
Shares Float (M) 90.52
% Held by Insiders 8.23
% Held by Institutions 70.12
Shares Short (K) 7830
Shares Short P. Month (K)

Stock Financials

EPS -2.563
EPS Est. Current Year -2.640
EPS Est. Next Year -1.720
EPS Est. Next Quarter -0.490
Forward EPS -1.100
Book Value (p.s.) 4.840
PEG Ratio
Profit Margin -82.14
Operating Margin -79.82
Return on Assets (ttm) -17.5
Return on Equity (ttm) -50.5
Qtrly Rev. Growth 58.2
Gross Profit (p.s.) -0.720
Sales Per Share
EBITDA (p.s.) -1.488
Qtrly Earnings Growth
Operating Cash Flow (M) -215.09
Levered Free Cash Flow (M) -178.46

Stock Valuations

P/E -1.67
P/E Growth Ratio 0.01
P/BV 0.88
P/S 161301984.00
P/CF -2.34

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.